Viewing Study NCT06908993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2025-12-27 @ 3:46 AM
Study NCT ID: NCT06908993
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Non Small Cell Lung Cancer View
None MET Exon 14 Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tepotinib View
None MET Exon 14 Mutation View
None Non Small Cell Lung Cancer View